The Human Immunodeficiency Virus - a Review of the clinical aspects and detection of the infection
DOI:
https://doi.org/10.12775/QS.2024.23.55368Keywords
HIV, Human Immunodeficiency Virus, ART, HIV manifestation, HIV detection, HIV diagnosis, HIV treatmentAbstract
Introduction: Currently, many people are infected with the human immunodeficiency virus (HIV). Transmission is primarily through sexual contact, with additional routes including mother-infant exposure to needles and needle sharing. Since the HIV/AIDS pandemic was first identified in 1981, more than 75 million people have been infected. Numerous new cases continue to be reported, and infection can become the starting point for the development of HIV. Clinical manifestations include acute retroviral syndrome, opportunistic infections, and dermatological, neuromuscular, and other complications. Despite advances in antiretroviral therapy (ART), challenges remain, including drug resistance, opportunistic infections, and persistent HIV reservoirs in some cell types. Early and accurate diagnosis is essential, and recommended testing protocols include fourth-generation serological tests and point-of-care (POC) testing. ART, which includes combinations of antiretroviral drugs, is the standard treatment, and ongoing research into gene therapy shows promise for the future.
Purpose of the work: The aim of this study is to review and characterize the clinical aspects and detection of human immunodeficiency virus infection.
Materials and methods: A comprehensive analysis of research papers available on PubMed, Google Scholar, Web of Science, Embase and Scopus was undertaken using the searchterms encompassing the following keywords: HIV, human immunodeficiency virus, ART, HIV manifestation, HIV detection, HIV diagnosis, HIV treatment.
References
Moir S, Chun TW, Fauci AS. Pathogenic mechanisms of HIV disease. Annu Rev Pathol. 2011;6:223-248. doi:10.1146/annurev-pathol-011110-130254
van Heuvel Y, Schatz S, Rosengarten JF, Stitz J. Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine. Toxins (Basel). 2022;14(2):138. Published 2022 Feb 14. doi:10.3390/toxins14020138
Fanales-Belasio E, Raimondo M, Suligoi B, Buttò S. HIV virology and pathogenetic mechanisms of infection: a brief overview. Ann Ist Super Sanita. 2010;46(1):5-14. doi:10.4415/ANN_10_01_02
De Cock KM, Jaffe HW, Curran JW. Reflections on 40 Years of AIDS. Emerg Infect Dis. 2021;27(6):1553-1560. doi:10.3201/eid2706.210284
The Urgency of Now: AIDS at a Crossroads: 2024 UNAIDS Global AIDS Update. Joint United Nations Programme on HIV/AIDS 2024. https://crossroads.unaids.org.
van Schalkwyk C, Mahy M, Johnson LF, Imai-Eaton JW. Updated Data and Methods for the 2023 UNAIDS HIV Estimates. J Acquir Immune Defic Syndr. 2024;95(1S):e1-e4. doi:10.1097/QAI.0000000000003344
Lobo Antuña M, Suárez EU, Calpena Martínez S, Lage Estebañez F, Fortes Alén J, de Górgolas Hernández-Mora M. Fever, Myalgias, and Weakness in a Patient with HIV. Am J Med. 2022;135(7):848-850. doi:10.1016/j.amjmed.2022.01.052
Hentzien M, Bonnet F, Bernasconi E, et al. Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol. BMC Infect Dis. 2024;24(1):329. Published 2024 Mar 19. doi:10.1186/s12879-024-09192-5
Mohseni Afshar Z, Goodarzi A, Emadi SN, et al. A Comprehensive Review on HIV-Associated Dermatologic Manifestations: From Epidemiology to Clinical Management. Int J Microbiol. 2023;2023:6203193. Published 2023 Jul 18. doi:10.1155/2023/6203193
Khondker L. Dermatological manifestations of HIV/AIDS patients. Journal of Enam Medical College. 2019;9(3):185–188. doi: 10.3329/jemc.v9i3.43249
Hira SK, Wadhawan D, Kamanga J, et al. Cutaneous manifestations of human immunodeficiency virus in Lusaka, Zambia. J Am Acad Dermatol. 1988;19(3):451-457. doi:10.1016/s0190-9622(88)70197-8
Emlet CA, Shippy RA. HIV/AIDS treatments. J Gerontol Soc Work. 2008;50 Suppl 1:131-49. doi: 10.1080/01634370802137850. PMID: 18924390.
Schifitto G, McDermott MP, McArthur JC, et al. Markers of immune activation and viral load in HIV-associated sensory neuropathy. Neurology. 2005; 64:842–848.5.546–55
Morgello S, Estanislao L, Simpson D, et al. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol. 2004;61:
Harrison TB, Smith B. Neuromuscular manifestations of HIV/AIDS. J Clin Neuromuscul Dis. 2011;13(2):68-84. doi:10.1097/CND.0b013e318221256f
Kaku M, Simpson DM. Neuromuscular complications of HIV infection. Handb Clin Neurol. 2018;152:201-212. doi:10.1016/B978-0-444-63849-6.00016-5
Pedersen C, Lindhardt BO, Jensen BL, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ. 1989;299(6692):154-157. doi:10.1136/bmj.299.6692.154
Kinloch-de Loës S, de Saussure P, Saurat JH, Stalder H, Hirschel B, Perrin LH. Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases. Clin Infect Dis. 1993;17(1):59-65. doi:10.1093/clinids/17.1.59
Simon D. Evaluation of diarrhea in HIV-infected patients. Gastrointest Endosc Clin N Am. 1998;8(4):857-867. doi:10.1016/S1052-5157(18)30236-8
Olmos M, Molina C, Piskorz E, et al. Diarrea y SIDA: técnicas diagnósticas más complejas; mejores resultados terapéuticos [Diarrhea and AIDS: more complex diagnostic techniques; better therapeutic results]. Acta Gastroenterol Latinoam. 1996;26(2):91-100.
De Munter P, Peetermans WE, Derdelinckx I, Vanderschueren S, Van Wijngaerden E. Fever in HIV-infected patients: less frequent but still complex. Acta Clin Belg. 2012;67(4):276-281. doi:10.2143/ACB.67.4.2062672
Tindall B, Barker S, Donovan B, et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med. 1988;148(4):945-949.
Apoola A, Ahmad S, Radcliffe K. Primary HIV infection. Int J STD AIDS. 2002;13(2):71-78. doi:10.1258/0956462021924613
Scaradavou A. HIV-related thrombocytopenia. Blood Rev. 2002;16(1):73-76. doi:10.1054/blre.2001.0188
Ballem PJ, Belzberg A, Devine DV et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med 1992; 327: 1779–1784.
Gauer RL, Braun MM. Thrombocytopenia. Am Fam Physician. 2012;85(6):612-622.
Kales CP, Holzman RS. Listeriosis in patients with HIV infection: clinical manifestations and response to therapy. J Acquir Immune Defic Syndr (1988). 1990;3(2):139-143.
Korn AP. Pelvic inflammatory disease in women infected with HIV. AIDS Patient Care STDS. 1998;12(6):431-434. doi:10.1089/apc.1998.12.431
Gökengin D, Wilson-Davies E, Nazlı Zeka A, et al. 2021 European guideline on HIV testing in genito-urinary medicine settings. J Eur Acad Dermatol Venereol. 2021;35(5):1043-1057. doi:10.1111/jdv.17139
Parczewski M, Witak-Jędra M, Aksak-Wąs B, red. Zasady opieki nad osobami zakażonymi HIV : zalecenia PTN AIDS 2023. Polskie Towarzystwo Naukowe AIDS; 2023.
Hans L, Allmen NV, Edelmann A, et al. Early Diagnosis of HIV-1 and HIV-2 Using Cobas HIV-1/HIV-2 Qualitative Test: A Novel Qualitative Nucleic Acid Amplification Test for Plasma, Serum, and Dried Blood Spot Specimens. J Acquir Immune Defic Syndr. 2021;87(5):1187-1195. doi:10.1097/QAI.0000000000002713
Lu H, Tang YW. Myths in the laboratory diagnosis of HIV infection. Emerg Microbes Infect. 2019;8(1):1240-1242. doi:10.1080/22221751.2019.1656550
Pittaway H, Barnard S, Wilson E et al. SH:24-user perspectives on an online sexual health service. Sex Transm Infect 2016; 92: A19–A20
https://www.eacsociety.org/guidelines/eacs-guidelines/
Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. Published 2021 Jul 23. doi:10.15585/mmwr.rr7004a1
Bekker LG, Beyrer C, Mgodi N, et al. HIV infection [published correction appears in Nat Rev Dis Primers. 2023 Sep 11;9(1):48. doi: 10.1038/s41572-023-00464-z]. Nat Rev Dis Primers. 2023;9(1):42. Published 2023 Aug 17. doi:10.1038/s41572-023-00452-3
Gulick RM, Flexner C. Long-Acting HIV Drugs for Treatment and Prevention. Annu Rev Med. 2019;70:137-150. doi:10.1146/annurev-med-041217-013717
Margolis DM, Koup RA, Ferrari G. HIV antibodies for treatment of HIV infection. Immunol Rev. 2017;275(1):313-323. doi:10.1111/imr.12506
Sang Y, Ding L, Zhuang C, Chen F. Design strategies for long-acting anti-HIV pharmaceuticals. Curr Opin Pharmacol. 2020;54:158-165. doi:10.1016/j.coph.2020.10.005
Huerta L. Editorial: Anti-infective 2020: HIV-From pathogenesis to treatment. Curr Opin Pharmacol. 2020;54:x-xii. doi:10.1016/j.coph.2020.12.001
Yang X, Su B, Zhang X, Liu Y, Wu H, Zhang T. Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders. J Leukoc Biol. 2020 Apr;107(4):597-612. doi: 10.1002/JLB.4MR1019-189R. Epub 2020 Jan 22. PMID: 31965635; PMCID: PMC7187275.
Pitman MC, Lau JSY, McMahon JH, Lewin SR. Barriers and strategies to achieve a cure for HIV. Lancet HIV. 2018;5(6):e317-e328. doi:10.1016/S2352-3018(18)30039-0
Avedissian SN, Dyavar SR, Fox HS, Fletcher CV. Pharmacologic approaches to HIV-associated neurocognitive disorders. Curr Opin Pharmacol. 2020;54:102-108. doi:10.1016/j.coph.2020.09.003
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Martyna Choinka, Agata Konopka, Natalia Wdowiak, Zuzanna Szczepaniak, Jakub Kalisiak, Anna Szpernalowska, Vimbisoyashe Ivy Matshaba, Karolina Mrugała
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 62
Number of citations: 0